rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Richard J. Hawkins

Director

Company insider

Files Form 4 as: Director, Cerenome; Director, Savara; Chief Executive Officer, Lumos Pharma; Director, Sciclone Pharmaceuticals.

Every Form 4 they filed

In numbers

Trades disclosed
156
Buys
9
Sells
11
Bought
$163K
Sold
$2.1M
Companies
4
Companies where not an officer
3
First trade
13 Jun 2006
Last trade
1 Oct 2026
Last filed
1 Oct 2026

Companies traded

Where they are an officer
Lumos PharmaDirector, Officer · last 12 Dec 20244 buys · 0 sells
Everywhere else they filed: board seats, 10% stakes, other companies
CNSY CerenomeDirector · Medical Devices · last 1 Oct 20264 buys · 0 sells
SVRA SavaraDirector · Biotechnology · last 9 Dec 20251 buy · 3 sells
Sciclone PharmaceuticalsDirector · last 13 Oct 20170 buys · 8 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
1 Oct 2026filed 1 Oct 2026CNSY CerenomeMedical DevicesSEC FORM 4 Code M—921 at $0.00filing
1 Oct 2026filed 1 Oct 2026CNSY Cerenomeoption or derivative · Medical DevicesSEC FORM 4 Code M—921 at $0.00filing
1 Jul 2026filed 1 Jul 2026Plus TherapeuticsMedical DevicesSEC FORM 4 Code M—922 at $0.00filing
1 Jul 2026filed 1 Jul 2026Plus Therapeuticsoption or derivative · Medical DevicesSEC FORM 4 Code M—922 at $0.00filing
1 Jul 2026filed 1 Jul 2026Plus Therapeuticsoption or derivative · Medical DevicesSEC FORM 4 Code M—922 at $0.00filing
1 Jul 2026filed 1 Jul 2026Plus TherapeuticsMedical DevicesSEC FORM 4 Code M—922 at $0.00filing
14 May 2026filed 18 May 2026Plus Therapeuticsoption or derivative · Medical DevicesSEC FORM 4 Code A—3,686 at $0.00filing
14 May 2026filed 18 May 2026Plus Therapeuticsoption or derivative · Medical DevicesSEC FORM 4 Code A—3,686 at $0.00filing
14 May 2026filed 18 May 2026Plus Therapeuticsoption or derivative · Medical DevicesSEC FORM 4 Code A—3,686 at $0.00filing
14 May 2026filed 18 May 2026Plus Therapeuticsoption or derivative · Medical DevicesSEC FORM 4 Code A—3,686 at $0.00filing
9 Dec 2025filed 11 Dec 2025SVRA SavaraBiotechnologySEC FORM 4 Code A—40,000 at $0.00filing
14 Nov 2025filed 17 Nov 2025SVRA Savaraoption or derivative · BiotechnologySEC FORM 4 Code M—5,860 at $0.00filing
14 Nov 2025filed 17 Nov 2025SVRA SavaraBiotechnologySEC FORM 4 Code M$8,5565,860 at $1.46filing
13 Aug 2025filed 15 Aug 2025Plus Therapeuticsoption or derivative · Medical DevicesSEC FORM 4 Code A—397,794 at $0.00filing
20 Jun 2025filed 23 Jun 2025SVRA SavaraBiotechnologySEC FORM 4 Bought$98K48,225 at $2.04filing
18 Feb 2025filed 20 Feb 2025Plus Therapeuticsoption or derivative · Medical DevicesSEC FORM 4 Code A—40,122 at $0.00filing
16 Dec 2024filed 16 Dec 2024SVRA SavaraBiotechnologySEC FORM 4 Sold$27K8,000 at $3.32filing
12 Dec 2024filed 16 Dec 2024SVRA SavaraBiotechnologySEC FORM 4 Code A—40,000 at $0.00filing
12 Dec 2024filed 13 Dec 2024Lumos Pharmaoption or derivativeSEC FORM 4 Code D—19,624filing
12 Dec 2024filed 13 Dec 2024Lumos Pharmaoption or derivativeSEC FORM 4 Code D—35,400filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Health Care8
Not placed12

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.